Growth Metrics

Axsome Therapeutics (AXSM) Amortization - Intangibles (2022 - 2025)

Historic Amortization - Intangibles for Axsome Therapeutics (AXSM) over the last 4 years, with Q3 2025 value amounting to $1.6 million.

  • Axsome Therapeutics' Amortization - Intangibles rose 6.23% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.4 million, marking a year-over-year decrease of 26.6%. This contributed to the annual value of $6.4 million for FY2024, which is 26.67% up from last year.
  • As of Q3 2025, Axsome Therapeutics' Amortization - Intangibles stood at $1.6 million, which was up 6.23% from $1.6 million recorded in Q2 2025.
  • Axsome Therapeutics' 5-year Amortization - Intangibles high stood at $1.6 million for Q3 2022, and its period low was $926000.0 during Q2 2022.
  • Its 4-year average for Amortization - Intangibles is $1.6 million, with a median of $1.6 million in 2023.
  • As far as peak fluctuations go, Axsome Therapeutics' Amortization - Intangibles surged by 7159.83% in 2023, and later tumbled by 106.99% in 2025.
  • Quarter analysis of 4 years shows Axsome Therapeutics' Amortization - Intangibles stood at $1.6 million in 2022, then changed by 0.0% to $1.6 million in 2023, then changed by 0.0% to $1.6 million in 2024, then changed by 0.0% to $1.6 million in 2025.
  • Its Amortization - Intangibles stands at $1.6 million for Q3 2025, versus $1.6 million for Q2 2025 and $1.6 million for Q1 2025.